Warrant [Member] Class of Warrant or Right [Axis] Restricted Stock Units [Member] Award Type [Axis] StockOptionPlanMember Stock Option Plan [Member] Warrant [Member] Options Granted To Consultants [Member] Mark Baum Chief Executive Officer [Member] Title of Individual [Axis] Consultant [Member] Employees - Selling, General And Administrative [Member] Related Party [Axis] Employees - Research And Development [Member] Directors - Selling, General And Administrative [Member] Director - Selling And Adminstrative [Member] Consultants - Selling, General And Adminstrative [Member] Consultants - Research And Development [Member] Major Types of Debt and Equity Securities [Axis] Range One [Member] Exercise Price Range [Axis] Stock Option 2 [Member] Stock Option 3 [Member] Stock Option 4 [Member] Stock Option 5 [Member] Options Granted To Employees [Member] Tranche 1 CEO [Member] Tranche 2 CEO [Member] Tranche 3 CEO [Member] Tranche 4 CEO [Member] Tranche 5 CEO [Member] Consultant Tranche 1 [Member] Consultant Tranche 2 [Member] Consultant Tranche 3 [Member] Consultant Tranche 4 [Member] Consultant Tranche 5 [Member] DermaStar [Member] April PPM [Member] Underwriter Warrants [member] IR Consultant [Member] Minimum [Member] Range [Axis] Maximum [Member] Stock Option Two [Member] Stock Option Three [Member] Dr. Robert J. Kammer [Member] Dr.Balbir Brar [Member] Consultant Two [Member] 450,000 Restricted Stock [Member] 600,000 Restricted Stock [Member] 100,000 Restricted Stock [Member] Range Two [Member] Range Three [Member] Range Four [Member] Range Five [Member] Tranche 1 CEO [Member] Tranche 2 CEO [Member] Tranche 3 CEO [Member] Consultant Tranche 1 [Member] Consultant Tranche 2 [Member] Consultant Tranche 3 [Member] Consultant Tranche 4 [Member] Consultant Tranche 5 [Member] IR Consultant 1 [Member] IR Consultant 2 [Member] Paul Finnegan [Member] Subsequent Event [Member] Subsequent Event Type [Axis] Peter Kenny [Member] Restricted Shares [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Entity's Current Reporting Status Entity Filer Category Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS Current assets Cash and cash equivalents Restricted short-term investment Prepaid expenses and other current assets Deferred offering costs Total current assets Furniture and equipment, net TOTAL ASSETS LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities Accounts payable and accrued expenses Accrued Phase 3 expenses Accrued payroll and related liabilities Deferred revenue Total current liabilities Commitments and contingencies STOCKHOLDERS' EQUITY Common stock, $0.001 par value, 395,000,000 shares authorized, 8,970,364 and 6,772,066 shares issued and outstanding at September 30, 2013 and December 31, 2012, respectively Additional paid-in capital Deficit accumulated during the development stage TOTAL STOCKHOLDERS' EQUITY TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY Common stock, par value Common stock, authorized shares Common stock, issued shares Common stock, outstanding shares Income Statement [Abstract] Revenues: License revenues Operating Expenses: Selling, general and administrative Research and development Loss from operations Other income (expense): Interest expense Interest income Loss on extinguishment of debt Gain on settlement Gain on forgiveness of liabilities Total other income (expense), net Net loss Deemed dividend to preferred stockholders Net loss attributable to common stockholders Net loss attributable to common stockholders per share of common stock, basic and diluted: Weighted average number of shares of common stock outstanding, basic and diluted Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES Net loss Adjustments to reconcile net loss to net cash used in operating activities: Estimated fair value of contributed services Gain on forgiveness of liabilities Amortization of prepaid consulting fees Depreciation Loss on extinguishment of debt Non-cash interest on notes payable Stock-based compensation Payments made on behalf of Company by related party Changes in assets and liabilities: Prepaid expenses and other current assets Accounts payable and accrued expenses Accrued Phase 3 expenses Accrued payroll and related liabilities Deferred revenue NET CASH USED IN OPERATING ACTIVITIES CASH FLOWS FROM INVESTING ACTIVITIES Purchase of restricted short-term investment Purchases of furniture and equipment NET CASH USED IN INVESTING ACTIVITIES CASH FLOWS FROM FINANCING ACTIVITIES Cancelled common stock Proceeds from issuance of notes payable to a related party Proceeds received in connection with debt modification Proceeds from issuance of preferred stock Proceeds from notes payable Preferred stock deemed dividend paid at conversion Cash advances from related party Repayment of advances from related party Capital contributions Net proceeds from purchase of common stock and exercise of warrants and stock options Proceeds from issuance of common stock and warrants for cash, net of offering costs NET CASH PROVIDED BY FINANCING ACTIVITIES NET CHANGE IN CASH AND CASH EQUIVALENTS CASH AND CASH EQUIVALENTS, beginning of period CASH AND CASH EQUIVALENTS, end of period SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: Cash paid for income taxes SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING ACTIVITIES: Issuance of and adjustment to common stock and warrants to consulting firms for prepaid consulting fees Deferred offering costs in connection with equity offering recorded in account payable Conversion of related party accounts payable into common stock Conversion of notes payable and accrued interest into common stock Forgiveness of notes payable and accrued interest to shareholders Conversion of advances to notes payable to shareholders Accretion of preferred stock discount Related party acquisition of Phase 3 liabilities Conversion of preferred stock into common stock Reclassification of deferred offering costs in connection with equity offering Issuance of common stock for consulting services included in accounts payable and accrued expenses Accounting Policies [Abstract] Overview, Basis of Presentation and Summary of Significant Accounting Policies Restricted Short-Term Investment Restricted Short-Term Investment Prepaid Expenses And Other Current Assets Prepaid Expenses and Other Current Assets Debt Disclosure [Abstract] Accounts Payable and Accrued Expenses Equity [Abstract] Stockholders' Equity and Stock-Based Compensation Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Subsequent Events [Abstract] Subsequent Events Company and Background Basis of Presentation Principles of Consolidation Development Stage Enterprise Research and Development Intellectual Property Revenue Recognition and Deferred Revenue Income Taxes Cash and Cash Equivalents Concentrations of Credit Risk Deferred Offering Costs Furniture and Equipment Deferred Rent Fair Value Measurements Stock-Based Compensation Basic and Diluted Loss per Common Share Use of Estimates Reclassifications Recently Issued Accounting Pronouncements Recently Adopted Accounting Pronouncements Stock Based Compensation and Equity Instruments Basic and Diluted Earnings Per Common Share Prepaid Expenses And Other Current Assets Tables Schedule of Prepaid Expenses and Other Current Assets Schedule of Accounts Payable and Accrued Expenses Schedule of Stock Option Plan Activity Schedule of Fair Value Assumption Schedule of Shares Outstanding and Exercisable Market Based Vesting Conditions for Restricted Stock Units Granted Schedule of Restricted Stock Units Activity Schedule of Warrants Activity Schedule of Warrants Issued Schedule of Warrants Outstanding and Warrants Exercisable Statement [Table] Statement [Line Items] Accumulated deficit during development stage Revenue Additional royalty payments based on percent of net sales Unrecognized tax benefits Common stock equivalents, dilutive instruments Deposit coverage limits by FDIC Cash deposits in excess of FDIC limits Compensation Expenses Numerator - net loss attributable to common stockholders Denominator - weighted average number of shares outstanding, basic and diluted Net loss per share, basic and diluted Restricted Short-Term Investment Details Narrative Certificate of deposit Prepaid Expenses And Other Current Assets - Schedule Of Prepaid Expenses And Other Current Assets Details Prepaid stock-based consulting expenses Prepaid Phase 3 expenses Prepaid insurance Other prepaid expenses and deposits Total prepaid expenses Restricted common stock underlying the stock-based compensation accrual Stock-based compensation related to restricted common stock issuances and accruals Stock based compensation expenses Accounts payable Accrued offering costs Deferred rent Other accrued expenses Stock-based compensation accrual Total accounts payable and accrued expenses Common stock issued shares Common stock price per share Common stock issued settle cashless exercise provision, shares Payment made on cancellation of common stock Payment made on cancellation of common stock, shares Number of underwritten public offering common stock shares closed Proceeds from public offerings Additional shares purchased by underwriters Net cash proceeds from the exercise of the over-allotment option Stock issued during period value issued to underwriters Underwriting agreement description Preferred stock, authorized shares Preferred stock, par value Preferred stock, shares issued Preferred stock, shares outstanding Closing price of common stock Number of shares, options granted Stock options granted to employees for acquiring aggregate common shares, number Stock options exercise price Stock option vesting period description Number of shares, options cancelled/forfeit Common stock shares issued for services Common stock issued for services Maximum shares of common stock available for issuance Remeasured fair value of restricted stock units Unrecognized compensation expense related to unvested stock options Weighted-average remaining vesting period Unamortized stock based compensation Percentage of forfeiture of stock option grants to employees and directors Stock-based compensation for stock options Restricted stock units issued Target ranging price Granted restricted stock units per person Granted restricted stock units Number of granted restricted stock units agreed to cancel Fair value of restricted stock units Unrecognized compensation expense related to restricted stock units Simulation period Volatility rate Risk free interest rate Number of restricted stock, forfeited Warrant issued to purchase number of common stock Warrants exercise price Warrants expire Warrants vesting period description Fair value of warrants Number of shares, Outstanding, Beginning balance Number of shares, Options granted Number of shares, Options exercised Number of shares, Options cancelled/forfeit Number of shares, Outstanding, Ending balance Number of shares, Options exercisable Number of shares, Options vested and expected to vest Weighted Avg. Exercise Price, Outstanding, Beginning balance Weighted Avg. Exercise Price, Options granted Weighted Avg. Exercise Price, Options exercised Weighted Avg. Exercise Price, Options cancelled/forfeit Weighted Avg. Exercise Price, Outstanding, Ending balance Exercisable Ending Balance Vested and expected to vest - end of period Weighted Avg. Remaining Contractual Life, Options outstanding Weighted Avg. Remaining Contractual Life, Options exercisable Weighted Avg. Remaining Contractual Life, Options vested and expected to vest Aggregate Intrinsic Value, Options outstanding Aggregate Intrinsic Value, Options exercisable Aggregate Intrinsic Value, Options vested and expected to vest Weighted-average fair value of options granted Expected terms (in years) Expected volatility, minimum Expected volatility, maximum Risk-free interest rate, minimum Risk-free interest rate, maximum Dividend yield Range of Exercise Prices, minimum Range of Exercise Prices, maximum Number of Options Outstanding Weighted Average Remaining Contractual Life in Years Weighted Average Exercise Price Number Exercisable Weighted Average Exercisable Exercise Price Percentage of Number of Shares Granted Number of Shares Target Share Price Number of RSUs, Outstanding, Beginning balance Number of RSUs granted Number of RSUs vested Number of RSUs cancelled/forfeit Number of RSUs, Outstanding, Ending balance Weighted Average Grant Date Fair Value, Beginning balance Weighted Average Grant Date Fair Value, RSUs granted Weighted Average Grant Date Fair Value, RSUs vested Weighted Average Grant Date Fair Value, RSUs cancelled/forfeit Weighted Average Grant Date Fair Value, Ending balance Number of shares, Outstanding, Beginning balance Number of Shares Subject to Warrants Outstanding, Granted Number of Shares Subject to Warrants Outstanding, Exercised Number of Shares Subject to Warrants Outstanding, Expired Number of shares, Outstanding, Ending balance Weighted average remaining contractual life of the outstanding warrants in years Weighted Avg. Exercise Price, Outstanding, Beginning balance Weighted Avg. Exercise Price, Granted Weighted Avg. Exercise Price, Exercised Weighted Avg. Exercise Price, Expired Weighted Avg. Exercise Price, Outstanding, Ending balance Weighted-average fair value of awards granted Expected terms Dividend yield Issue Date Warrants Outstanding Exercise Price Warrants Exercisable Expiration Date Lease agreement for office space (Square feet) Operating lease Expiry Operating lease, monthly rental Operating lease, rent increase percentage Total lease obligation is approximately Operating lease due current One time payment for acquire lease Royalties range percentage Maximum aggregate value of cash fees Option issued to purchase number of common stock Option exercise price Stock options vesting period description Accrued offering costs Additional royalty payments based on percent of net sales. Amortization of prepaid consulting fees April PPM Restricted common stock underlying the stock-based compensation accrual Common stock issued settle cash less exercise provision shares. Company and Background Consultant Consultant Tranche 1 Consultant Tranche 2 Consultant Tranche 3 Consultant Tranche 4 Consultant Tranche 5 ConsultantsResearchAndDevelopment [Member] Conversion of advances to notes payable to shareholders Conversion of preferred stock into common stock Conversion of related party accounts payable into common stock Deferred Offering Costs Deferred offering costs in connection with equity offering recorded in account payable DermaStar Development Stage Enterprise Dilutive instruments. DirectorSellingAndAdminstrativeMember Directors selling general and administrative [Member] EmployeesResearchAndDevelopmentMember Employees selling general and administrative [Member] Estimated fair value of contributed services Tranche 1 CEO Tranche 2 CEO Tranche 3 CEO Tranche 4 CEO Tranche 5 CEO Forgiveness of notes payable and accrued interest to shareholders. Gain on forgiveness of liabilities IR Consultant Issuance of and adjustment to common stock and warrants to consulting firms for prepaid consulting fees Maximum deposit coverage limits. New adopted accounting pronouncements policy [PolicyTextBlock]. Number Exercisable Number of Shares Number of underwritten public offering common stock shares closed. Options granted to employees Options granted to consultants Other accrued expenses Related party acquisition of Phase 3 liabilities Percentage of Number of Shares Granted. Preferred stock deemed dividend paid at conversion Prepaid expenses and other current assets disclosure [Text Block]. Prepaid Phase Three Expenses Prepaid Stock Based Consulting Expenses Proceeds from issuance of notes payable to a related party Proceeds received in connection with debt modification Reclassification Of Deferred Offering CostsIn Connectionwit Equity Offering Remeasured fair value of restricted stock units Market-based vesting conditions for Restricted Stock Units Granted Schedule Of Prepaid Expenses And Other Current AssetsTable Text Block Schedule Of Restrited Stock Units Activity Schedule Of Warrants Activity Schedule Of Warrants Issued Schedule of Warrants Outstanding And Warrants Exercisable Warrants Outstanding Exercise Price Vested Weighted Average Exercisable Exercise Price Warrants Exercisable Stock Based Compensation Expenses Related Totermination Of Consulting Agreement Stock issued during period shares issued to underwriters. Stock issued during period value issued to underwriters. StockOption2Member StockOption3Member StockOption4Member StockOption5Member StockOptionPlanMember Stock-based compensation accrual Target Share Price Underwriter Warrants Unrecognized compensation expense related to unvested stock options Warrant Stock Option Two [Member] Stock Option Three [Member] Consultant Two [Member] Four Lakhs Fifty Thousand Restricted Stock [Member] Six Lakhs Restricted Stock [Member] One Lakh Restricted Stock [Member] Underwriting Agreement Description Closing Price Of Common Stock Investment Options Exercise Price Stock Option Vesting Period Description Unamortised Stock based Compensation Percentage Of Forfeiture Of Stock Option Grants Target Ranging Price Restricted Stock Units Granted During Period Per Person Cancellation Of Restricted Stock Units During Period Warrants Expired Duration Warrants Vesting Period Description Executive Restricted Stock Units Tranche One [Member] Executive Restricted Stock Units Tranche Two [Member] Executive Restricted Stock Units Tranche Three [Member] Consultant Tranche One [Member] Consultant Tranche Two [Member] Consultant Tranche Three [Member] Consultant Tranche Four [Member] Consultant Tranche Five [Member] Consultant One [Member] Consultant Two [Member] Royalties Range Percentage Aggregate Value Of Cash Fees Peter Kenny [Member] Intellectual property [policy text block] Consultants selling general and adminstrative [Member] Restricted shares [member]. Range one [member]. Range two [member]. Range three [member]. Range four [member]. Range five [member] Warrants issue date. Warrants expiration date. Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Exercisable Weighted Average Remaining Contractual Term Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises In Period Weighted Average Exercise Price Share Based Compensation Arrangements By Share Based Payment Award Non Options Expirations In Period Weighted Average Exercise Price Options Exercise Price Option Issued To Purchase Number Of Common Stock Stock Options Granted To Employees For Acquiring Aggregate Common Shares Number WarrantActivityMember ExecutiveRestrictedStockUnitsTrancheOneMember ExecutiveRestrictedStockUnitsTrancheTwoMember ExecutiveRestrictedStockUnitsTrancheThreeMember ConsultantTrancheOneMember ConsultantTrancheTwoMember ConsultantTrancheThreeMember ConsultantTrancheFourMember ConsultantTrancheFiveMember Assets, Current Assets Liabilities, Current Development Stage Enterprise, Deficit Accumulated During Development Stage Stockholders' Equity Attributable to Parent Liabilities and Equity Operating Income (Loss) Interest Expense, Other Debt Instrument, Decrease, Forgiveness Other Nonoperating Expense Preferred Stock Dividends and Other Adjustments GainOnForgivenessOfLiabilities Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Accounts Payable and Accrued Liabilities Increase (Decrease) in Other Accounts Payable and Accrued Liabilities Increase (Decrease) in Employee Related Liabilities Increase (Decrease) in Deferred Revenue Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities Payments for Repurchase of Common Stock Repayments of Related Party Debt Net Cash Provided by (Used in) Financing Activities Cash and Cash Equivalents, Period Increase (Decrease) Cash, Cash Equivalents, and Short-term Investments [Text Block] Accounts Payable and Accrued Liabilities Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice Fair Value Assumptions, Weighted Average Expected Dividend